University of Chicago: Neoplasm Metastasis trials
The registry lists 12 Neoplasm Metastasis studies with University of Chicago as lead sponsor. 4 are open to participants now and 1 have results posted.
Phase 1 7Phase 2 3Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI CancersNot yet recruitingNCT07126561Phase 2
- Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCCRecruitingNCT06912087Phase 1
- Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.Not yet recruitingNCT06660862Phase 4
- Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic CancersRecruitingNCT04295863Phase 1
- Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate CancerCompletedNCT01599793Phase 2Results posted
- Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid LevelsWithdrawnNCT04931420Phase 2
- Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After TransplantCompletedNCT02485535Phase 1
- Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of ResponseTerminatedNCT01258634Phase 1
- Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic CancerCompletedNCT01215500Phase 1
- Rapamycin Plus Bevacizumab in Advanced CancersCompletedNCT00667485Phase 1
- Rapamycin With Grapefruit Juice for Advanced MalignanciesCompletedNCT00375245Phase 1